Eli Lilly and Company
The role leads technical development, scale-up and technology transfer of GMP radiopharmaceutical manufacturing processes and analytical methods, and authors CMC documentation to support regulatory filings. The position is part of the Translational Radiochemistry team within Early Phase CMC and supports early-phase radiopharmaceutical programs across internal and external sites.
Headquarters
Indianapolis, Indiana, United States
Company Size
10001+ employees
Founded
1876
Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Eli Lilly and Company.
Li Auto OTA Upgrade And Charging Use Test Investor Patience
1 week ago
Scientist II, Radiochemistry
Telix Pharmaceuticals
Associate Director, CMC Development
ARTBIO
NIF Radiochemistry Manager
University of Sydney Union (USU)
Chief Attending, Radiochemistry & Imaging Sciences Service
Memorial Sloan Kettering Cancer Center
Radiochemistry Scientist I
Ratio Therapeutics
Scientist, Radiochemistry
AstraZeneca